Skip to content
Screener

ADMA Biologics ADMA Ratios & Valuation

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
Profitability
Gross margin64.7%+11.7pp61.3%+8.7pp57.4%+5.9pp54.7%+5.8pp53%+6.9pp
Operating margin43.8%+11.0pp42.1%+9.0pp37.5%+4.9pp34.2%+4.2pp32.8%+7.4pp
Net margin33%-11.1pp32.4%-12.6pp28.8%-17.6pp42.9%+25.1pp44.1%+33.5pp
Returns
Return on equity41.9%-29.3pp43.3%-35.2pp35.6%-46.1pp63.2%+27.6pp71.2%+50.5pp
Return on invested capital44.1%-28.5pp44.8%-25.8pp38.6%-27.1pp54.9%-26.0pp72.6%+10.6pp
Efficiency
Asset turnover0.8×-0.2×0.9×-0.2×0.9×-0.1×1×0.0×1×+0.1×
Liquidity
Current ratio7×+1.6×7×+0.4×6.7×+0.7×7.1×0.0×5.3×-1.5×
Leverage
Debt-to-equity0.5×+0.5×0.5×+0.5×0.2×-0.1×0.2×+0.1×0×0.0×
Net debt / EBITDA0.3×+0.8×0.3×+0.7×-0×+0.1×0.1×+0.8×-0.5×+0.5×
Per Share
Book value per share$1.77+10.6%$1.63+6.6%$1.95+35.9%$1.76+86.1%$1.60+106%
Valuation
Market capitalization$2.25B-49.1%$2.15B-54.5%$4.34B+7.1%$3.5B-24.9%$4.26B+64.4%
Price / earnings13.3×-7.9×13×-9.8×29.5×+9.0×16.7×-51.7×20.4×-54.1×
Price / sales4.4×-4.9×4.2×-6.1×8.5×-1.0×7.2×-5.0×9×+1.1×
Price / book5.5×-5.6×5.5×-7.1×9.1×-2.5×8.1×-12.0×10.7×-3.1×
EV / EBITDA10×-16.6×9.9×-19.2×21.7×-5.8×20.1×-20.2×25.6×-6.1×

FAQ

What are ADMA Biologics's profit margins?
ADMA Biologics (ADMA) runs a 64.7% gross margin and a 43.8% operating margin, with a 33.0% net margin.
Where do ADMA Biologics's ratios come from?
Every ratio is computed from ADMA Biologics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.